InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-62.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Blumenkranz Mark S., Director. Insider active across 4 companies, notably IVERIC bio, Inc.. Cumulatively, 13 filings have been recorded. History available since 15 July 2022. The latest transaction was filed on 11 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
1,400 shares0Common StockSEC:0001415889-24-016569:0
32,088 sharesCommon StockSEC:0001104659-23-080692:0
3,784 shares0Common StockSEC:0001415889-23-010282:0
3 sharesCommon StockSEC:0001415889-23-009139:0
14,588 sharesCommon StockSEC:0001410939-23-000078:0
4,534 shares@ US$18.00100.0% of flowCommon StockSEC:0001562180-23-001846:0
5,000 shares0Common StockSEC:0001410939-22-000084:0
4,534 sharesCommon StockSEC:0001562180-22-004856:0
7,500 sharesCommon StockSEC:0001410939-22-000067:0
157,765 sharesCommon StockSEC:0001415889-21-005278:0
157,765 sharesCommon StockSEC:0001415889-21-005278
5,000 sharesCommon StockSEC:0001104659-21-093460
5,000 sharesCommon StockSEC:0001104659-21-093460:0
13 of 13 declarations
About Blumenkranz Mark S.
Mark S. Blumenkranz is a Director at IVERIC bio, Inc., Kala Pharmaceuticals, Inc., and 1Life Healthcare Inc. As a board member, he participates in overseeing the activities of the companies and making strategic decisions. Blumenkranz brings valuable insight through his experience in the biopharmaceutical sector, thereby contributing to the governance and direction of the companies.
